isosorbide-5-mononitrate has been researched along with Primary Peritonitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abraldes, JG; Bosch, J; Garcia-Pagan, JC; Rodés, J; Tarantino, I; Turnes, J | 1 |
Balanzo, J; Cusso, X; Gallego, A; Gonzalez-Suarez, B; Guarner, C; Minana, J; Sainz, S; Soriano, G; Torras, X; Villanueva, C | 1 |
1 trial(s) available for isosorbide-5-mononitrate and Primary Peritonitis
Article | Year |
---|---|
Pharmacologic treatment of portal hypertension in the prevention of community-acquired spontaneous bacterial peritonitis.
Topics: Adrenergic beta-Antagonists; Bacterial Infections; Community-Acquired Infections; Drug Therapy, Combination; Epidemiologic Methods; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Peritonitis; Sclerotherapy; Secondary Prevention; Vasodilator Agents | 2006 |
1 other study(ies) available for isosorbide-5-mononitrate and Primary Peritonitis
Article | Year |
---|---|
Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
Topics: Antihypertensive Agents; Ascites; Bacterial Infections; Cohort Studies; Drug Therapy, Combination; Female; Hemodynamics; Hemorrhage; Hepatic Encephalopathy; Hepatorenal Syndrome; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Probability; Prognosis; Propranolol; Recurrence; Risk Factors; Survival Analysis; Time Factors; Varicose Veins; Vasodilator Agents | 2003 |